Paul V. Plourde

1.4k total citations
26 papers, 995 citations indexed

About

Paul V. Plourde is a scholar working on Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Paul V. Plourde has authored 26 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Paul V. Plourde's work include Acute Lymphoblastic Leukemia research (7 papers), Estrogen and related hormone effects (6 papers) and Advanced Breast Cancer Therapies (5 papers). Paul V. Plourde is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Estrogen and related hormone effects (6 papers) and Advanced Breast Cancer Therapies (5 papers). Paul V. Plourde collaborates with scholars based in United States, United Kingdom and Israel. Paul V. Plourde's co-authors include Martin C. Dyroff, Michael Dukes, Alan Webster, Aman U. Buzdar, Stephen E. Jones, Charles L. Vogel, Janet Wolter, Edward O. Reiter, Stephen D. Rubin and Erica A. Eugster and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Paul V. Plourde

25 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul V. Plourde United States 14 442 274 248 211 209 26 995
Oreste E. Salavaggione United States 16 223 0.5× 167 0.6× 282 1.1× 119 0.6× 468 2.2× 25 988
B.M.J. Cantwell United Kingdom 19 159 0.4× 62 0.2× 421 1.7× 109 0.5× 338 1.6× 52 1.1k
Luíz Henrique Gebrim Brazil 15 202 0.5× 101 0.4× 251 1.0× 206 1.0× 147 0.7× 92 735
Margaret R. Spitz United States 17 273 0.6× 190 0.7× 398 1.6× 430 2.0× 1.2k 5.9× 24 1.8k
Teresa Ramón y Cajal Spain 19 434 1.0× 69 0.3× 357 1.4× 243 1.2× 360 1.7× 59 956
Audrey Barlock United States 12 451 1.0× 46 0.2× 487 2.0× 380 1.8× 207 1.0× 13 1.0k
Yuko Yamamura United States 17 145 0.3× 109 0.4× 345 1.4× 219 1.0× 221 1.1× 31 1.1k
Honglin Song United Kingdom 24 498 1.1× 132 0.5× 441 1.8× 315 1.5× 904 4.3× 41 1.6k
Paul D.P. Pharoah United Kingdom 14 997 2.3× 79 0.3× 529 2.1× 389 1.8× 489 2.3× 17 1.5k
Maria Gaetana Di Mauro Italy 16 314 0.7× 53 0.2× 196 0.8× 142 0.7× 572 2.7× 27 918

Countries citing papers authored by Paul V. Plourde

Since Specialization
Citations

This map shows the geographic impact of Paul V. Plourde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul V. Plourde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul V. Plourde more than expected).

Fields of papers citing papers by Paul V. Plourde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul V. Plourde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul V. Plourde. The network helps show where Paul V. Plourde may publish in the future.

Co-authorship network of co-authors of Paul V. Plourde

This figure shows the co-authorship network connecting the top 25 collaborators of Paul V. Plourde. A scholar is included among the top collaborators of Paul V. Plourde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul V. Plourde. Paul V. Plourde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Damodaran, Senthil, Massimo Cristofanilli, Matthew P. Goetz, et al.. (2024). Abstract PO2-14-09: Baseline genomic alterations and the activity of lasofoxifene (LAS) plus abemaciclib (Abema) in patients with ER+/HER2- metastatic breast cancer (mBC): the ELAINE 2 study. Cancer Research. 84(9_Supplement). PO2–14. 1 indexed citations
2.
Damodaran, Senthil, Halle C. F. Moore, Mathew Cherian, et al.. (2023). Lasofoxifene (LAS) plus abemaciclib (Abema) for treating ESR1-mutated ER+/HER2- metastatic breast cancer (mBC) after progression on prior therapies: ELAINE 2 study update.. Journal of Clinical Oncology. 41(16_suppl). 1057–1057. 5 indexed citations
3.
Blau, Sibel, Julio A. Peguero, Halle C. F. Moore, et al.. (2023). Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model. JCO Clinical Cancer Informatics. 7(7). e2200164–e2200164. 1 indexed citations
4.
Vrooman, Lynda M., Ivan I. Kirov, ZoAnn E. Dreyer, et al.. (2015). Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli‐Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. 63(2). 228–233. 41 indexed citations
5.
Salzer, Wanda L., et al.. (2014). Development of asparaginaseErwinia chrysanthemifor the treatment of acute lymphoblastic leukemia. Annals of the New York Academy of Sciences. 1329(1). 81–92. 42 indexed citations
6.
Plourde, Paul V., Sima Jeha, Nobuko Hijiya, et al.. (2014). Safety profile of asparaginaseErwinia chrysanthemiin a large compassionate‐use trial. Pediatric Blood & Cancer. 61(7). 1232–1238. 47 indexed citations
7.
Salzer, Wanda L., Barbara L. Asselin, Jeffrey G. Supko, et al.. (2013). Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children’s Oncology Group. Blood. 122(4). 507–514. 57 indexed citations
8.
Plourde, Paul V., Sima Jeha, Nobuko Hijiya, et al.. (2012). L-Asparaginase (L-ASP) Related Toxicities with Asparaginase Erwinia Chrysanthemi in a Large Compassionate Use Protocol.. Blood. 120(21). 2568–2568. 1 indexed citations
9.
10.
Lowe, Elizabeth, et al.. (2008). The Aromatase Inhibitor Anastrozole Is Ineffective in the Treatment of Precocious Puberty in Girls with McCune-Albright Syndrome. The Journal of Clinical Endocrinology & Metabolism. 93(7). 2751–2754. 35 indexed citations
11.
Plourde, Paul V., Edward O. Reiter, Paul E. Desrochers, et al.. (2004). Safety and Efficacy of Anastrozole for the Treatment of Pubertal Gynecomastia: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 89(9). 4428–4433. 79 indexed citations
12.
Eugster, Erica A., et al.. (2003). Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. The Journal of Pediatrics. 143(1). 60–66. 78 indexed citations
13.
14.
Buzdar, Aman U., Paul V. Plourde, & G. N. Hortobagyi. (1996). Aromatase inhibitors in metastatic breast cancer.. PubMed. 23(4 Suppl 9). 28–32. 16 indexed citations
15.
Jonat, W., A. Buzdar, Anthony Howell, et al.. (1995). 351 Two randomised trials establishing efficacy and tolerability of arimidex (ZD1033) in the treatment of postmenopausal women with advanced breast cancer (PABC). European Journal of Cancer. 31. S76–S76. 3 indexed citations
16.
Plourde, Paul V., Martin C. Dyroff, Mitch Dowsett, et al.. (1995). ARIMIDEX™: A new oral, once-a-day aromatase inhibitor. The Journal of Steroid Biochemistry and Molecular Biology. 53(1-6). 175–179. 100 indexed citations
17.
Plourde, Paul V., Martin C. Dyroff, & Michael Dukes. (1994). Arimidex�: A potent and selective fourth-generation aromatase inhibitor. Breast Cancer Research and Treatment. 30(1). 103–111. 204 indexed citations
18.
Plourde, Paul V., et al.. (1985). Impotence Associated with Low Biological to Immunological Ratio of Luteinizing Hormone in a Man with a Pituitary Stone. The Journal of Clinical Endocrinology & Metabolism. 60(4). 797–802. 9 indexed citations
19.
Plourde, Paul V., James G. Marks, & James M. Hammond. (1984). Acanthosis nigricans and insulin resistance. Journal of the American Academy of Dermatology. 10(5). 887–891. 5 indexed citations
20.
Page, Robert B., et al.. (1983). Intrasellar mixed germ-cell tumor. Journal of neurosurgery. 58(5). 766–770. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oreste E. Salavaggione Breakdown of academic impact, for papers by B.M.J. Cantwell Breakdown of academic impact, for papers by Luíz Henrique Gebrim Breakdown of academic impact, for papers by Margaret R. Spitz Breakdown of academic impact, for papers by Teresa Ramón y Cajal Breakdown of academic impact, for papers by Audrey Barlock Breakdown of academic impact, for papers by Yuko Yamamura Breakdown of academic impact, for papers by Honglin Song Breakdown of academic impact, for papers by Paul D.P. Pharoah Breakdown of academic impact, for papers by Maria Gaetana Di Mauro
Rankless by CCL
2026